Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mili Duggal"'
Publikováno v:
Open Forum Infectious Diseases
Background CURE ID is an internet-based repository developed collaboratively by FDA and NCATS/NIH, with the support of WHO and IDSA. It encourages clinicians globally to share novel uses of existing drugs for patients with difficult-to-treat infectio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5de98c44daa4476aea8dfff7d341bb0
http://europepmc.org/articles/PMC7777160
http://europepmc.org/articles/PMC7777160
Publikováno v:
Open Forum Infectious Diseases
Background Multi and extensively drug-resistant (MDR and XDR) tuberculosis (TB) remains a treatment challenge due to drug adverse events (AEs) and long regimens. Our aim was to identify AEs which resulted from repurposing drugs for MDR and XDR-TB. Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3df49b4fccff171ffe9b73f06f790259
https://doi.org/10.1093/ofid/ofz360.1244
https://doi.org/10.1093/ofid/ofz360.1244
Autor:
Leonard V. Sacks, Noel Southall, Mili Duggal, Rosemary Tiernan, Timothy Sheils, Heather Stone
Publikováno v:
Open Forum Infectious Diseases
Background Repurposing approved products has proven a critical strategy to serve unmet medical needs. Historically, 40% of drugs approved for treatment of tropical diseases were repurposed, including albendazole for echinococcosis and neurocysticerco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::914c4c829b5cc15ee75f2f5893a69f4d
http://europepmc.org/articles/PMC5631680
http://europepmc.org/articles/PMC5631680